Biocon Latest News

  1. Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products
    Date:19-01-2018
  2. Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products
    Date:18-01-2018
  3. Biocon has informed about Press Release titled ‘Biocon and Mylans Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through Their Partner Libbs’.

    The above information is a part of c...

    Date:29-12-2017
  4. This is the first biosimilar Trastuzumab to be approved in Brazil
    Date:29-12-2017
  5. The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil J Pathare.

    The above information is a part of com...

    Date:28-12-2017
  6. The special resolution was passed with 99.99 per cent of votes polled through postal ballot
    Date:11-12-2017
  7. The special resolution was passed with 99.99 per cent of votes polled through postal ballot
    Date:09-12-2017
  8. The company has received EMA regulator nod for proposed biosimilar trastuzumab, pegfilgrastim
    Date:05-12-2017
  9. The company has received EMA regulator nod for proposed biosimilar trastuzumab, pegfilgrastim
    Date:04-12-2017
  10. Pegfilgrastim is used to reduce the duration of neutropenia and the incidence of fever associated with neutropenia in adult patients treated with chemotherapy in certain types of cancer
    Date:01-12-2017
Return to Top
Connect with us Facebook
Connect with us Facebook
Connect with us Linkedin
Connect with us Pintrest
Connect with us Google Plus
Connect with us You Tube
Connect with us Mobile App
 
 
Request a Call Back
Mobile
Invalid Mobile Number
x
Thanks. We will call you shortly.